173 related articles for article (PubMed ID: 11426550)
21. The combination of arsenic, interferon-alpha, and zidovudine restores an "immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia lymphoma.
Kchour G; Rezaee R; Farid R; Ghantous A; Rafatpanah H; Tarhini M; Kooshyar MM; El Hajj H; Berry F; Mortada M; Nasser R; Shirdel A; Dassouki Z; Ezzedine M; Rahimi H; Ghavamzadeh A; de Thé H; Hermine O; Mahmoudi M; Bazarbachi A
Retrovirology; 2013 Aug; 10():91. PubMed ID: 23962110
[TBL] [Abstract][Full Text] [Related]
22. Interferon-alpha, zidovudine, and granulocyte-macrophage colony-stimulating factor: a phase I AIDS Clinical Trials Group study in patients with Kaposi's sarcoma associated with AIDS.
Krown SE; Paredes J; Bundow D; Polsky B; Gold JW; Flomenberg N
J Clin Oncol; 1992 Aug; 10(8):1344-51. PubMed ID: 1634925
[TBL] [Abstract][Full Text] [Related]
23. Zidovudine and interferon-alpha treatment induces a high response rate and reduces HTLV-1 proviral load and VEGF plasma levels in patients with adult T-cell leukemia from North East Iran.
Kchour G; Makhoul NJ; Mahmoudi M; Kooshyar MM; Shirdel A; Rastin M; Rafatpanah H; Tarhini M; Zalloua PA; Hermine O; Farid R; Bazarbachi A
Leuk Lymphoma; 2007 Feb; 48(2):330-6. PubMed ID: 17325893
[TBL] [Abstract][Full Text] [Related]
24. [Adult T-cell leukemia/lymphoma. Therapeutic aspects].
Besson C; Plumelle Y; Arnulf B; Gonin C; Panelatti G; Bazarbachi A; Hermine O
Presse Med; 2001 Feb; 30(5):243-5. PubMed ID: 12385063
[TBL] [Abstract][Full Text] [Related]
25. Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-{alpha}-refractory adult T-cell leukemia.
Mone A; Puhalla S; Whitman S; Baiocchi RA; Cruz J; Vukosavljevic T; Banks A; Eisenbeis CF; Byrd JC; Caligiuri MA; Porcu P
Blood; 2005 Nov; 106(10):3380-2. PubMed ID: 16076875
[TBL] [Abstract][Full Text] [Related]
26. Zidovudine and Interferon Alfa based regimens for the treatment of adult T-cell leukemia/lymphoma (ATLL): a systematic review and meta-analysis.
Shafiee A; Seighali N; Taherzadeh-Ghahfarokhi N; Mardi S; Shojaeian S; Shadabi S; Hasani M; Haghi S; Mozhgani SH
Virol J; 2023 Jun; 20(1):118. PubMed ID: 37287047
[TBL] [Abstract][Full Text] [Related]
27. In vivo and in vitro treatment of HTLV-1 and HTLV-2 infected cells with arsenic trioxide and interferon-alpha.
Mahieux R; Hermine O
Leuk Lymphoma; 2005 Mar; 46(3):347-55. PubMed ID: 15621824
[TBL] [Abstract][Full Text] [Related]
28. Temozolomide in combination with interferon alpha-2b in patients with metastatic melanoma: a phase I dose-escalation study.
Agarwala SS; Kirkwood JM
Cancer; 2003 Jan; 97(1):121-7. PubMed ID: 12491513
[TBL] [Abstract][Full Text] [Related]
29. A case series of adult T-cell leukemia-lymphoma, associated with human T-cell leukemia virus type-1, at a single center in a non-viral-endemic metropolitan area.
Akuzawa Y; Tsukasaki K; Saeki T; Okamura D; Ishikawa M; Maeda T; Kohri M; Takahashi N; Matsuda A; Kawai N; Asou N
J Clin Exp Hematop; 2019; 59(3):108-111. PubMed ID: 31564712
[TBL] [Abstract][Full Text] [Related]
30. A surprising advance in the treatment of viral leukemia.
Gallo RC
N Engl J Med; 1995 Jun; 332(26):1783-5. PubMed ID: 7760898
[No Abstract] [Full Text] [Related]
31. How I treat adult T-cell leukemia/lymphoma.
Cook LB; Phillips AA
Blood; 2021 Jan; 137(4):459-470. PubMed ID: 33075812
[TBL] [Abstract][Full Text] [Related]
32. HIV-related non-Hodgkin's lymphoma: CHOP induction therapy and interferon-alpha-2b/zidovudine maintenance therapy.
Weiss R; Huhn D; Mitrou P; Nerl C; Schürmann D; Scheidegger C; Knauf W; Trenn G; Kronawitter U; Van Lunzen J; Arastéh K; Herbst H
Leuk Lymphoma; 1998 Mar; 29(1-2):103-18. PubMed ID: 9638980
[TBL] [Abstract][Full Text] [Related]
33. Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives.
Bazarbachi A; Hermine O
Virus Res; 2001 Oct; 78(1-2):79-92. PubMed ID: 11520582
[TBL] [Abstract][Full Text] [Related]
34. Treatment of Philadelphia chromosome-positive chronic myelogenous leukemia with weekly polyethylene glycol formulation of interferon-alpha-2b and low-dose cytosine arabinoside.
Garcia-Manero G; Talpaz M; Giles FJ; Cortes J; Faderl S; O'Brien S; Thomas D; Verstovsek S; Beth Rios M; Shan J; Ferrajoli A; Wierda W; Kantarjian HM
Cancer; 2003 Jun; 97(12):3010-6. PubMed ID: 12784336
[TBL] [Abstract][Full Text] [Related]
35. Activity of interferon-alpha and isotretinoin in patients with advanced, refractory lymphoid malignancies.
Tsimberidou AM; Giles F; Romaguera J; Duvic M; Kurzrock R
Cancer; 2004 Feb; 100(3):574-80. PubMed ID: 14745875
[TBL] [Abstract][Full Text] [Related]
36. Atypical presentation of adult T-cell leukaemia/lymphoma due to HTLV-1: prurigo nodularis lasting twelve years followed by an acute micropapular eruption.
Duval A; Rivet J; Moulonguet I; Cassar O; Agbalika F; Wallach D; Gessain A; Petit A
Acta Derm Venereol; 2010 May; 90(3):287-90. PubMed ID: 20526548
[TBL] [Abstract][Full Text] [Related]
37. RETINAL MANIFESTATIONS IN ADULT T-CELL LEUKEMIA/LYMPHOMA RELATED TO INFECTION BY THE HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-1.
Merle H; Hage R; Meniane JC; Deligny C; Plumelle Y; Donnio A; Jean-Charles A
Retina; 2016 Jul; 36(7):1364-71. PubMed ID: 26716955
[TBL] [Abstract][Full Text] [Related]
38. Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma.
Ishitsuka K; Tamura K
Lancet Oncol; 2014 Oct; 15(11):e517-26. PubMed ID: 25281470
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of interferon-alfa and mid-cycle chemotherapy added to an anthracycline-based regimen in the treatment of aggressive non-Hodgkin's lymphoma.
Enschede SH; Shahidi H; Venugopal P; Riley MB; Huang R; Jajeh A; Preisler HD; Gregory SA
Leuk Lymphoma; 2001 Jan; 40(3-4):325-34. PubMed ID: 11426554
[TBL] [Abstract][Full Text] [Related]
40. Recent advances in the treatment of adult T-cell leukemia-lymphomas.
Utsunomiya A; Choi I; Chihara D; Seto M
Cancer Sci; 2015 Apr; 106(4):344-51. PubMed ID: 25613789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]